Emergencies preparedness, response

Nigeria launches Yellow fever vaccination campaign

WHO team provides health services in north-eastern Nigeria
WHO/P. Ajello

20 December 2018 Abuja – The Government of Nigeria with support from the World Health Organization (WHO), and partners launched this week a Yellow fever reactive vaccination campaign , funded by Gavi, the Vaccine Alliance. The campaign will be implemented in 13 Local Government Areas (LGAs) of Edo state where cases have been confirmed. The immunization drive is a response to the unprecedented yellow fever outbreak recently identified in the State. More than 1.4 million people age from 9 months to 44 years old are expected to be protected in this seven-day campaign.

Ebola vaccine provides protection, trial confirms

Ebola vaccine trial
S. Hawkey

23 December 2016 – An experimental Ebola vaccine was highly protective against the deadly virus in a major trial, according to results published today in The Lancet. The vaccine is the first to prevent infection from one of the most lethal known pathogens, and the findings add weight to early trial results published last year. The vaccine, called rVSV-ZEBOV, was studied in a trial involving 11 841 people in Guinea during 2015.

Recovery toolkit: health services after Ebola

May 2016 -- The recovery toolkit is online library of guidance resources to support countries in the reactivation of health services which may have suffered as a result of an emergency, such as the Ebola outbreak. These services include ongoing programmes such as immunization, maternal and child health services, infection prevention and control.


Our vision

An integrated global alert and response system for epidemics and other public health emergencies based on strong national public health systems and capacity and an effective international system for coordinated response.

Core functions

  • Support Member States for the implementation of national capacities for epidemic preparedness and response in the context of the IHR(2005), including laboratory capacities and early warning alert and response systems;
  • Support national and international training programmes for epidemic preparedness and response;
  • Coordinate and support Member States for pandemic and seasonal influenza preparedness and response;
  • Develop standardized approaches for readiness and response to major epidemic-prone diseases (e.g. meningitis, yellow fever, plague);
  • Strengthen biosafety, biosecurity and readiness for outbreaks of dangerous and emerging pathogens outbreaks (e.g. SARS, viral haemorrhagic fevers); Maintain and further develop a global operational platform to support outbreak response and support regional offices in implementation at regional level.

Latest publications